Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study 2019-07-04 21:05
NeuroVive Receives KL1333 Clinical Trial Regulatory Approval 2018-10-10 14:49
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) 2018-05-31 20:09
NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development 2018-05-21 17:26
NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases 2018-04-18 15:57
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ) 2018-02-15 16:35
NeuroVive Board Chair Resigns, New Chair Elected 2017-11-07 15:55
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million 2017-11-03 16:33
1